Xizang Haisco Pharmaceutical Group Co Ltd (002653) — Financial Flexibility Index
Xizang Haisco Pharmaceutical Group Co Ltd (002653) has a Financial Flexibility Index of 0.04x as of September 2025. Free cash flow of CN¥112.14 Million (operating CF CN¥39.68 Million minus capex CN¥72.46 Million) represents 0% of total liabilities (CN¥2.99 Billion). Check how aggressively does Xizang Haisco Pharmaceutical Group Co Lt reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Xizang Haisco Pharmaceutical Group Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Xizang Haisco Pharmaceutical Group Co Ltd across 18 annual periods. For the full cash flow conversion analysis, see 002653 cash generation efficiency.
Annual Financial Flexibility Index for Xizang Haisco Pharmaceutical Group Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Xizang Haisco Pharmaceutical Group Co Ltd. Explore 002653 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.41x | CN¥1.12 Billion | CN¥786.00 Million | CN¥2.72 Billion | ▲ +20.8% |
| 2024 | 0.34x | CN¥882.70 Million | CN¥442.05 Million | CN¥2.60 Billion | ▲ +0.4% |
| 2023 | 0.34x | CN¥840.59 Million | CN¥449.58 Million | CN¥2.48 Billion | ▲ +24.2% |
| 2022 | 0.27x | CN¥794.71 Million | CN¥94.55 Million | CN¥2.91 Billion | ▼ -23.0% |
| 2021 | 0.35x | CN¥738.74 Million | CN¥35.80 Million | CN¥2.09 Billion | ▼ -5.9% |
| 2020 | 0.38x | CN¥807.93 Million | CN¥206.21 Million | CN¥2.15 Billion | ▼ -25.7% |
| 2019 | 0.51x | CN¥1.35 Billion | CN¥764.26 Million | CN¥2.66 Billion | ▲ +45.7% |
| 2018 | 0.35x | CN¥824.59 Million | CN¥472.61 Million | CN¥2.37 Billion | ▼ -5.3% |
| 2017 | 0.37x | CN¥785.07 Million | CN¥391.81 Million | CN¥2.14 Billion | ▼ -10.9% |
| 2016 | 0.41x | CN¥617.44 Million | CN¥409.20 Million | CN¥1.50 Billion | ▼ -39.3% |
| 2015 | 0.68x | CN¥726.70 Million | CN¥443.03 Million | CN¥1.07 Billion | ▼ -29.4% |
| 2014 | 0.96x | CN¥737.43 Million | CN¥502.57 Million | CN¥767.55 Million | ▼ -30.4% |
| 2013 | 1.38x | CN¥732.40 Million | CN¥568.41 Million | CN¥530.24 Million | ▼ -44.2% |
| 2012 | 2.47x | CN¥590.05 Million | CN¥464.75 Million | CN¥238.49 Million | ▼ -24.9% |
| 2011 | 3.29x | CN¥378.52 Million | CN¥260.79 Million | CN¥114.95 Million | ▲ +29.9% |
| 2010 | 2.54x | CN¥448.33 Million | CN¥367.38 Million | CN¥176.79 Million | ▲ +38.5% |
| 2009 | 1.83x | CN¥392.22 Million | CN¥368.21 Million | CN¥214.22 Million | ▲ +92.7% |
| 2008 | 0.95x | CN¥131.82 Million | CN¥94.45 Million | CN¥138.73 Million | — |